Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

22.2%

2 terminated/withdrawn out of 9 trials

Success Rate

77.8%

-8.7% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
6(75.0%)
Phase 1
2(25.0%)
8Total
Phase 2(6)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT01805674Completed

Isoflavones and Magnolia Extract in the Quality of Life in Menopausal Women

Role: lead

NCT01562080Phase 2Completed

Combined Effects of Bioactive Compounds in Lipid Profile

Role: lead

NCT00503516Phase 2Terminated

Study to Evaluate the Effect of Megestrol Acetate in Weight Loss in Dementia Patients

Role: lead

NCT00507949Phase 2Completed

Study to Evaluate the Effect of Megestrol Acetate in Severe Chronic Obstructive Pulmonary Disease With Loss of Weight

Role: lead

NCT00748787Phase 2Terminated

Trial to Evaluate the Effect of Plantago Ovata Husk in the Remission of Metabolic Syndrome in Children and Adolescents

Role: lead

NCT00425074Phase 1Completed

Pharmacodynamic-pharmacokinetic Trial, of Slow Release ASA, in the Platelet Functionalism.

Role: lead

NCT00507715Phase 1Completed

Study of the Modification of the Pharmacokinetic Profile of Levodopa by the Fiber Plantago Ovata Husk

Role: lead

NCT00501254Phase 2Completed

Pharmacodynamic Trial, of Slow Release ASA, in Platelet Functionalism, a Long Term Treatment Period

Role: lead

NCT00502047Phase 2Completed

Effect of the Plantago Ovata Husk on the Lipid Profile of Patients With Hypercholesterolemia

Role: lead

All 9 trials loaded